Glutamate drugs and pharmacogenetics of OCD: a pathway-based exploratory approach

Author： Grados Marco A   Specht Matt W   Sung Hyung-Mo   Fortune Diandra  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.8, Iss.12, 2013-12, pp. : 1515-1527

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pathway-based Approaches to Pharmacogenomics

By  

Current Pharmacogenomics, Vol. 5, Iss. 1, 2007-03 ,pp. : 79-86

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamate Hypothesis of Schizophrenia and Approach for Possible Therapeutic Drugs

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 4, Iss. 2, 2004-06 ,pp. : 147-154

Bentham Science Publishers

Access to resources Recommend Favorite

Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors

By Mitra Amit K   Kirstein Mark N   Khatri Amit   Skubitz Keith M   Dudek Arkadiusz Z   Greeno Edward W   Kratzke Robert A   Lamba Jatinder K  

Pharmacogenomics, Vol. 13, Iss. 9, 2012-07 ,pp. : 1009-1021

Future Medicine

Access to resources Recommend Favorite

Glutamate-Based Drugs for the Treatment of Clinical Depression

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 8, Iss. 3, 2008-09 ,pp. : 170-176

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of Antithrombotic Drugs

By  

Current Pharmaceutical Design, Vol. 12, Iss. 19, 2006-07 ,pp. : 2425-2435

Bentham Science Publishers

Access to resources Recommend Favorite